Sean Dickson, a drug policy expert who has published frequently cited research on 340B, has gone to work for the health insurance industry.
Sean Dickson, a drug policy expert who has published frequently cited research on the 340B program and advised both health care providers and drug manufacturers on 340B compliance, has gone to work for the health insurance industry.
340B contract pharmacy and third-party administration services company Avita has acquired Q Care Plus, a business that helps patients access PrEP by telehealth.
Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, has acquired Q Care Plus, a business that helps patients access HIV pre-exposure prophylaxis (PrEP) medication by telehealth.
Maintaining regular access to providers is a challenge for many 340B grantee entities and can make it hard for them to leverage the 340B program, Avita CEO Michael Yount says.
Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, is expanding into medical practice staffing and management.
Avita announced Oct. 5 that it has acquired HIV/AIDS, LGBTQ+, and primary
Walgreens Boots Alliance (WBA) announced September 20th that it is acquiring the remaining 30% stake in 340B specialty pharmacy company Shields Health Solutions that it did not already own.
Walgreens Boots Alliance (WBA) announced September 20th that it is acquiring the remaining 30% stake in 340B specialty pharmacy company Shields Health Solutions that it did not already own. WBA first invested in Shields in July 2019. Last year,
Tony Megna, CEO of one of the profitable health centers investigated by Kaiser Health News, said, "“We ask, why is there an implication that surplus funds come at the expense of our mission?" | Phil Galewitz / KHN
Community health center advocates have strongly criticized a new Kaiser Health News (KHN) investigative report that found that some health centers have large profit margins.
The article found that nine of the nation’s nearly 1,400 health centers reported
AIDS Healthcare Foundation recently refreshed its let340b.org website, roughly the same time as PhRMA ran a full-page ad in The Washington Post saying the 340B program doesn't help patients.
The brand drug industry’s recent full-page ad in The Washington Post saying the 340B program helps big hospitals and chain pharmacies but not patients is “hypocritical slander,” AIDS Healthcare Foundation President Michael Weinstein said last week.
Beth Peery is the 340B Coordinator at Memorial Health Systems in Seward, Nebraska, a town of 6,000 in the southeastern part of the state.
A Special Report From 340B Report: A two-part series on the growing frustrations safety net providers face in restoring access to 340B pricing in the contract pharmacy setting. Part 1 provides important background on the challenges that
A Special Report From 340B Report: A two-part series on the growing frustrations safety net providers face in restoring access to 340B pricing in the contract pharmacy setting. Part 1 provides important background on the challenges that covered
Seventy-one percent of hospital pharmacy leaders surveyed said their facility offered at least one in-house outpatient and/or specialty pharmacy and over half of those lacking such a pharmacy said they planned to open one at some point.
Hospital outpatient pharmacy leaders cite staffing shortages, managing multiple vendors, and navigating insurer red tape—specialty drug referrals and prior authorization requirements, specifically—among top workplace challenges, a new survey finds. As 340B providers continue to grapple with pharmaceutical manufacturer
